Skip to content

Anxiolytic Effect of Virtual Reality Immersion Versus Midazolam Premedication in Patients Undergoing Dacryocystorhinostomy Surgery

Randomized Clinical Trial for Comparison Between the Anxiolytic Effect of Virtual Reality Immersion Versus Midazolam Premedication in Patients Undergoing Dacryocystorhinostomy Surgery

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07050095
Enrollment
40
Registered
2025-07-03
Start date
2025-06-01
Completion date
2025-12-30
Last updated
2025-07-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiolytic Effect, Virtual Reality Immersion, Midazolam, Premedication, Dacryocystorhinostomy

Brief summary

The aim is to investigate the anxiolytic effect, and hemodynamic stability of using virtual reality immersion in adult patients undergoing Dacryocystorhinostomy (DCR) operation under general anesthesia and to compare its effect to that of using Midazolam as a premedication.

Detailed description

Anxiety is a negative emotion characterized by fear, tension, and nervousness. Preoperative anxiety is anxiety due to disease, hospitalization, or scheduled surgery. The most common causes of preoperative anxiety are waiting for surgery, worrying about the operation outcome, being separated from family, anticipating postoperative pain, losing independence, and being afraid of surgery, pain, and death. Midazolam reduces anxiety by acting on GABAA receptors, resulting in sedation; however, the benefit of midazolam premedication remains debatable, and the drug's side effects include paradoxical reactions, oversedation, reduced blood pressure, and respiratory depression. Regarding this, some clinicians challenge the clinical benefits of benzodiazepine premedication and contend that non-pharmacological treatments alone are sufficient to minimize preoperative anxiety. Virtual reality is a computer technology that creates the sensation of being immersed in a simulated three-dimensional environment in which the user can interact with the virtual environment. It has also been suggested as a non-pharmaceutical alternative for lowering surgical pain and anxiety. Dacryocystorhinostomy (DCR) is a procedure that circumvents the blocked tear duct and offers an alternate path for the drainage of tears from the eye to the nose and is most effectively performed under a general anesthetic.

Interventions

OTHERVirtual Reality Group

Patient will undergo virtual reality (VR) immersion using oculus.

Patient will receive midazolam premedication only.

Sponsors

Cairo University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Aged 18-65. * Both sexes. * American Society of Anesthesiologists (ASA) classification: I - II. * Patient undergoing Dacryocystorhinostomy Surgery (DCR) operation under general anesthesia.

Exclusion criteria

* Patient refusal. * Patients with cardiac diseases. * Patients with renal diseases. * Patients with drug sensitivity and seizures. * Substance abuse and addiction. * Claustrophobia. * Patients with cerebrovascular disease. * Psychiatric and cognitive disorder. * Patients with severe teary eyes and blurring of vision. * Patients who express discomfort during the test.

Design outcomes

Primary

MeasureTime frameDescription
Anxiety Score15-minute after interventionBeck Anxiety Inventory (BAI) score change measured from pre- to post-intervention (virtual reality (VR) or midazolam). The score ranges from 0 to 63. A greater reduction indicates better anxiolytic effect.5 minutes before intervention and Immediately after the 15-minute virtual reality (VR) session or midazolam injection

Secondary

MeasureTime frameDescription
Systolic blood pressure (SBP)After intubation (Up to 2 hours)Systolic blood pressure (SBP) recorded to evaluate cardiovascular response to premedication and induction.At four time points: T1 (initial on the day of surgery), T2 (before induction), T3 (before intubation), and T4 (after intubation).
Diastolic blood pressure (DBP)After intubation (Up to 2 hours)Diastolic blood pressure (DBP) measured to monitor hemodynamic changes related to stress and sedation.At four time points: T1 (initial on the day of surgery), T2 (before induction), T3 (before intubation), and T4 (after intubation).
Heart rate (HR)After intubation (Up to 2 hours)Heart rate (HR) measured to assess perioperative hemodynamic response to anxiolytic intervention.At four time points: T1 (initial on the day of surgery), T2 (before induction), T3 (before intubation), and T4 (after intubation).
Patient Satisfaction2 hours Post interventionSurvey with options: very satisfied, satisfied, undecided, or unsatisfied
Incidence of ComplicationsFirst 30 minutes post-extubationPresence of headache, dizziness, nausea, or virtual reality (VR)related discomfort.
Mean blood pressure (MBP)After intubation (Up to 2 hours)Mean blood pressure (MBP) recorded to reflect overall perfusion pressure during perioperative period.At four time points: T1 (initial on the day of surgery), T2 (before induction), T3 (before intubation), and T4 (after intubation).

Countries

Egypt

Contacts

Primary ContactHebatullah S Abdelhamid, MD
drhebasalah593@gmail.com002 01044512277

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026